ST elevation myocardial infarction management of patients who were not reperfused

For patient information click here

Associate Editor-In-Chief:

Side Effects
==ACC/AHA Guidelines (DO NOT EDIT) ==

{{cquote|

Class I
1. It is reasonable for patients with STEMI who do not undergo reperfusion therapy to be treated with anticoagulant therapy (non-UFH regimen) for the duration of the index hospitalization, up to 8 days. (Level of Evidence: B) Convenient strategies that can be used include those with LMWH (Level of Evidence: C) or fondaparinux (Level of Evidence: B) using the same dosing regimens as for patients who receive fibrinolytic therapy.}}